Luz Alcaraz
Family · Sacramento, CANPI 1295793552
Payments from drug & device makers
Across 326 payments — averaging $16.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$882
- Lilly USA, LLC$803
- Boehringer Ingelheim$424
- AbbVie$397
- AstraZeneca$347
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$320
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,435100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 73 | $882 |
| Lilly USA, LLC | 56 | $803 |
| Boehringer Ingelheim | 20 | $424 |
| AbbVie | 25 | $397 |
| AstraZeneca | 18 | $347 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 23 | $320 |
| GSK | 12 | $254 |
| Exact Sciences | 11 | $237 |
| Astellas Pharma US Inc | 9 | $209 |
| Amgen | 10 | $202 |
| Johnson & Johnson | 9 | $145 |
| Collegium Pharmaceutical, Inc. | 6 | $133 |
| Ardelyx, Inc. | 5 | $127 |
| Merck | 5 | $97 |
| Amarin Pharma, Inc. | 4 | $81 |
| Pfizer | 4 | $79 |
| Gilead | 3 | $75 |
| Kowa Pharmaceuticals America, Inc. | 3 | $65 |
| Phathom Pharmaceuticals, Inc. | 4 | $59 |
| Esperion Therapeutics, Inc. | 3 | $57 |
| Eisai Inc. | 3 | $53 |
| Nestle Healthcare Nutrition Inc. | 2 | $50 |
| Biohaven Pharmaceuticals, Inc. | 2 | $48 |
| Sanofi-aventis U.S. LLC | 3 | $46 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $39 |
| Ironwood Pharmaceuticals, Inc | 2 | $32 |
| Boston Scientific | 1 | $29 |
| Braintree Laboratories, Inc. | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Myovant Sciences Inc. | 1 | $20 |
| Bayer | 1 | $18 |
| Abbott | 1 | $17 |
| Radius Health, Inc. | 1 | $15 |
| VBI Vaccine (delaware) Inc. | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$104
How this compares
$5,435 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 35 | $38,194 |
| OzempicSemaglutide | 32 | $29,791 |
| LinzessLinaclotide | 23 | $19,786 |
| EliquisApixaban | 17 | $17,677 |
| MounjaroTirzepatide | 17 | $16,725 |
| VascepaIcosapent Ethyl | 18 | $6,608 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $3,192 |
| Atorvastatin Calcium | 198 | $2,746 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $2,151 |
| Levothyroxine Sodium | 133 | $1,849 |
| Losartan Potassium | 149 | $1,760 |
| Glipizide-MetforminGlipizide/Metformin Hcl | 16 | $1,729 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 12 | $1,649 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,478 |
| Metoprolol Succinate | 97 | $1,417 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $424 | $38,19435 claims |
| Novo NordiskOzempic | $882 | $29,79132 claims |
| AbbVieLinzess | $397 | $19,78623 claims |
| PfizerEliquis | $79 | $17,67717 claims |
| Lilly USA, LLCMounjaro | $803 | $16,72517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.
Other family in Sacramento
- Kim SchaferSacramento$288K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.